Erratum: MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (17438–17443) DOI: 10.1073/pnas.1903150116)

Gayathri Srinivasan, Elizabeth A. Williamson, Kimi Kong, Aruna S. Jaiswal, Guangcun Huang, Hyun Suk Kim, Orlando Schärer, Weixing Zhao, Sandeep Burma, Patrick Sung, Robert Hromas

Research output: Contribution to journalComment/debate

Abstract

Correction for “MEDICAL SCIENCES Correction for “MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers,” by Gayathri Srinivasan, Elizabeth A. Williamson, Kimi Kong, Aruna S. Jaiswal, Guangcun Huang, Hyun-Suk Kim, Orlando Schärer, Weixing Zhao, Sandeep Burma, Patrick Sung, and Robert Hromas, which was first published August 8, 2019; 10.1073/pnas.1903150116 (Proc. Natl. Acad. Sci. U.S.A. 116, 17438-17443). The authors note that the grant number for the Cancer Prevention and Research Institute of Texas Research Training Award to G.S. should instead appear as RP170345, rather than RP17035.

Original languageEnglish (US)
Pages (from-to)8658
Number of pages1
JournalProceedings of the National Academy of Sciences of the United States of America
Volume117
Issue number15
DOIs
StatePublished - Apr 14 2020

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Erratum: MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (17438–17443) DOI: 10.1073/pnas.1903150116)'. Together they form a unique fingerprint.

  • Cite this